Clinical depression and regulation of the inflammatory response during acute stress

Psychosomatic Medicine

Volumn 67, Issue 5, 2005, Pages 679-687

  Miller, Gregory E ^a   Rohleder, Nicolas ^b   Stetler, Cinnamon ^a   Kirschbaum, Clemens ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Acute stress; Cortisol; Cytokines; Depression; Inflammation; Reactivity

Indexed keywords

C REACTIVE PROTEIN; DEXAMETHASONE; ENDOTOXIN; GLUCOCORTICOID; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE; MENTAL STRESS; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; SHAME;

EID: 25844485949     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000174172.82428.ce     Document Type: Article

References (67)

1. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270: 1819-25.
2. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105: 1049-53.
3. Lesperance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000;160: 1354-60.
4. Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C, Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-33.
5. Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM et al. Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosom Med 2004;66:466-74.
6. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control - a meta-analytic review of the literature. Diab Care 2000;23:934-42.
7. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63:619-30.
8. Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom Med 2003;65:376-83.
9. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, Tillinger W, Gangl A, Moser G. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004;66:79-84.
10. Zautra AJ, Burleson MH, Matt KS, Roth SA. Interpersonal stress, depression, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol 1994;13:139-48.
11. Zautra AJ, Yocum DC, Villanueva I, Smith B, Davis MC, Attrep J et al. Immune activation and depression in women with rheumatoid arthritis. J Rheumatol 2004;31:457-63.
12. Irwin MR. Depression and immunity. In: Ader R, Felten D, Cohen N, editors. Psychoneuroimmunology, Third ed. New York: Academic Press; 2001. p. 383-98.
13. Kop WJ, Cohen N. Psychological risk factors and immune system involvement in cardiovascular disease. In: Ader R, Felten D, Cohen N, editors. Psychoneuroimmunology, Third ed. New York: Academic Press; 2001. p. 525-44.
14. Papanicoloaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
15. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
16. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress, and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2001;148:209-14.
17. Choy EHS, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
18. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-83.
19. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997;9: 853-8.
20. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004;164:1010-4.
21. Irwin MR. Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun 2002;16:16.
22. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 1999;4:182-88.
23. Anisman H, Ravindran AV, Griffiths J, Merali Z. Interleukin-1β production in dysthymia before and after pharmacotherapy. Biol Psychiatry 1999;46:1655.
24. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000;22:370-79.
25. Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 2000; 62:583-606.
26. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J et al. Inflammatory and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002;89:419-24.
27. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol Biol Sci Med Sci 1999;54:M434-9.
28. Suarez EC, Krishnan KR, Lewis JG. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med 2003;65:362-8.
29. Dentino AN, Pieper CF, Rao KMK, Currie MS, Harris T, Blazer DG et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatric Soc 1999;47:6-11.
30. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 2003;17:268-75.
31. Suarez EC. Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med 2003;65:523-7.
32. Wilckens T, DeRijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997;18:418-24.
33. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49: 391-404.
34. Miller GE, Freedland KE, Carney R. Depressive symptoms and the regulation of pro-inflammatory cytokine expression in patients with coronary heart disease. J Psychosom Res 2005. In press.
35. Haskett RF. The HPA axis and depressive disorders. In: Mann JJ, Kupfer DJ, editors. Biology of Depressive Disorders. New York: Plenum Press; 1993. p. 171-88.
36. Segerstrom SC, Miller GE. Psychological stress and the immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004;130: 601-30.
37. Rohleder N, Schommer NC, Hellhammer DH, Engel R, Kirschbaum C. Sex differences in the glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med 2001;63: 966-72.
38. Rohleder N, Joksimovic L, Wolf JM, Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry 2004;55:745-51.
39. Rohleder N, Wolf JM, Fiel M, Kirschbaum C. Impact of oral contraceptive use on glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. Psychoneuroendocrinology 2003;28: 261-73.
40. Dopp JM, Miller GE, Myers HF, Fahey JL. Increased natural killer-cell mobilization and cytotoxicity during marital conflict. Brain Behav Immun 2000;14:10-26.
41. Peelers F; Nicholson NA, Berkhof J. Cortisol responses to daily events in major depressive disorder. Psychosom Med 2003;65:836-41.
42. Trestman RL, Coccaro EF, Bernstein D, Lawrence T, Gabriel SM, Horvath TB, et al. Cortisol responses to mental arithmetic in acute and remitted depression. Biol Psychiatry 1991;29:1051-4.
43. Burke HM, Davis MC, Otte C, Mohr DC. Depression and cortisol responses to psychological stress: A meta-analysis. Psychoneuroendocrinology 2005.
44. Miller GE, Cohen S, Herbert TB. Pathways linking major depression and immunity in ambulatory female patients. Psychosom Med 1999;61: 850-60.
45. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: American Psychiatric Association; 1994.
46. Freedland KE, Skala JA, Carney RM, Raczynski JM, Taylor CB, Mendes de Leon CF et al. The Depression Interview and Structured Hamilton (DISH): Rationale, development, characteristics, and clinical validity. Psychosom Med 2002;64:897-905.
47. Robins LN, Helzer JE, Croughan J, Ratcliff K. The NIMH Diagnostic Interview Schedule: Its history, characteristics, and validity. Arch Gen Psychiatry 1981;38:381-9.
48. Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy FV, Hahn SR et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-56.
49. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. J App Psychol Meas 1977;1:385-401.
50. Kirschbaum C, Pruessner JC, Stone AA, Federenko I, Gaab J, Lintz D et al. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 1995;57:468-74.
51. Usala PD, Hertzog C. Measurement of affective states in adults: Evaluation of an adjective rating scale instrument. Res Aging 1989;11:403-26.
52. DeRijk R, Petrides J, Deuster P, Gold PW, Sternberg EM. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J Clin Endocrinol Metab 1996;81:228-35.
53. Ebrecht M, Buske-Kirschbaum A, Hellhammer D, Kern S, Rohleder N, Walker BR et al. Tissue specificity of glucocorticoid sensitivity in healthy adults. J Clin Endocrinol Metab 2000;85:3733-9.
54. Dickerson SS, Kemeny ME. Acute Stressors and cortisol responses: A theoretical integration and synthesis of laboratory research. Psychol Bull 2004;130:355-91.
55. Gruenewald TL, Kemeny ME, Aziz N, Fahey JL. Acute threat to the social self: shame, social self-esteem, and cortisol activity. Psychosom Med 2004;66:915-24.
56. Steptoe A, Willemsen G, Owen N, Flower L, Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci 2001;101:185-92.
57. Steptoe A, Owen N, Kunz-Ebrecht S, Mohamed-Ali V. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav Immun 2002;16:774-84.
58. Steuer CA, Miller GE. Blunted cortisol response to awakening in mild to moderate depression: Regulatory influences of sleep patterns and social contacts. J Abnorm Psychol 2005. In press.
59. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-72.
60. Miller AH, Pariante CM, Pearce BD. Effects of cytokines on glucocorticoid receptor expression and function. Adv Exp Med Biol 1999;461:107-16.
61. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman SL, Checkley S et al. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 2003;28:49-65.
62. DeRijk R, Sternberg EM. Corticosteroid resistance and disease. Ann Med 1997;29:79-82.
63. Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid resistance model. Health Psychol 2002;21:531-41.
64. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
65. Mills PJ, Berry CC, Dimsdale JE, Ziegler M, Nelesen RA, Kennedy BP. Lymphocyte subset redistribution in response to acute experimental stress; Effects of gender, ethnicity, hypertension, and the sympathetic nervous system. Brain Behav Immun 1995;9:61-9.
66. Benschop RJ, Schedlowski M, Wienecke H, Jacobs R, Schmidt RE. Adrenergic control of natural killer cell circulation and adhesion. Brain Behav Immun 1997;11:321-32.
67. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamic-pituitary-adrenal axis. Psychosom Med 1999;61:154-62.